Alopecia areata: an update on etiopathogenesis, diagnosis, and management

C Zhou, X Li, C Wang, J Zhang - Clinical Reviews in Allergy & …, 2021 - Springer
Alopecia areata (AA) is a common chronic tissue-specific autoimmune disease, resulting in
hair loss, that affects up to 2% of the general population. The exact pathobiology of AA has …

Alopecia areata: Current understanding of the pathophysiology and update on therapeutic approaches, featuring the Japanese Dermatological Association guidelines

M Fukuyama, T Ito, M Ohyama - The Journal of dermatology, 2022 - Wiley Online Library
Alopecia areata (AA) is a relatively common nonscarring hairloss disease characterized by
an autoimmune response to anagen hair follicles (HFs). Accumulated evidence suggests …

Alopecia areata

A Gilhar, A Etzioni, R Paus - New England Journal of Medicine, 2012 - Mass Medical Soc
Alopecia Areata | New England Journal of Medicine Skip to main content The New England
Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES Cardiology …

The burden of alopecia areata: a scoping review focusing on quality of life, mental health and work productivity

A Muntyanu, S Gabrielli, J Donovan… - Journal of the …, 2023 - Wiley Online Library
Alopecia areata (AA) is a common inflammatory autoimmune disease of the hair which can
have a significant negative impact on quality of life (QoL), mental health and productivity …

The autoimmune basis of alopecia areata: a comprehensive review

N Islam, PSC Leung, AC Huntley, ME Gershwin - Autoimmunity reviews, 2015 - Elsevier
Alopecia areata (AA) is a common, non-scarring dermatologic condition regularly
distinguished by patches of hair loss on the scalp also manifesting in other, severe forms …

A randomized, double‐blind, placebo‐and active‐controlled, half‐head study to evaluate the effects of platelet‐rich plasma on alopecia areata

A Trink, E Sorbellini, P Bezzola… - British Journal of …, 2013 - academic.oup.com
Background Alopecia areata (AA) is a common autoimmune condition, causing inflammation‐
induced hair loss. This disease has very limited treatment possibilities, and no treatment is …

Comorbidities in alopecia areata: a systematic review and meta-analysis

S Lee, H Lee, CH Lee, WS Lee - Journal of the American Academy of …, 2019 - Elsevier
Background Alopecia areata (AA) may be associated with various systemic diseases
according to several studies. Objective To identify prevalent and incident diseases in …

Treatment of alopecia areata: an Australian expert consensus statement

WC Cranwell, VWY Lai, L Photiou… - Australasian Journal …, 2019 - Wiley Online Library
Alopecia areata (AA) severity varies from a single small patch to complete loss of scalp hair,
body hair, eyelashes and eyebrows. While 40% of all affected individuals only ever get one …

Alopecia areata profiling shows TH1, TH2, and IL-23 cytokine activation without parallel TH17/TH22 skewing

M Suárez-Fariñas, B Ungar, S Noda, A Shroff… - Journal of Allergy and …, 2015 - Elsevier
Background Alopecia areata (AA) is a common T cell–mediated disorder with limited
therapeutics. A molecular profile of cytokine pathways in AA tissues is lacking. Although …

Autoimmune, atopic, and mental health comorbid conditions associated with alopecia areata in the United States

KP Huang, S Mullangi, Y Guo, AA Qureshi - JAMA dermatology, 2013 - jamanetwork.com
Objective To evaluate the prevalence of comorbid conditions among patients with alopecia
areata (AA) seen at tertiary care hospitals in Boston, Massachusetts, during an 11-year …